Tosional better than longitudinal ultrasound in phaco

Article

Phacoemulsification procedures consume significantly less fluid using torsional compared with longituinal ultrasound in hard cataract cases, according to Khiun Tjia of the Netherlands.

Phacoemulsification procedures consume significantly less fluid using torsional compared with longituinal ultrasound in hard cataract cases, according to Khiun Tjia of the Netherlands.

At the Isala Clinics, Zwolle, Netherlands, hard cataracts were graded and yellow nuclei or denser were selected for the study. Cataracts were randomized to undergo either torsional (16) or longitudinal (16) ultrasound phaco procedures. Identical fluid dynamic parameters were set and the same tapered Kelman 45º tip was used. Torsional ultrasound was used in 100% continuous mode and longitudinal in pulse mode with 50% duty-cycle and 30 pulses/sec. All surgeries were performed by the same surgeon with a fast crack divide and conquer technique.

Torsional ultrasound used less fluid during the sculpt phase than longitudinal and significantly less than the longitudinal (p=0.0001) during irrigation/aspiration of cortical material. The quantities were similar during viscoelastice removal. Total fluid consumption for the two procedures was as follows: Torsional = 54.58 ml, longitudinal = 66.64 ml.

Tjia concluded that, since torsional ultrasound uses significantly less fluid it is a more efficient procedure than longitudinal ultrasound.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.